[Cellular immunity and humoral immunity in non-A, non-B hepatitis]. 1988

K Yoshizawa, and K Kiyosawa, and S Furuta

UI MeSH Term Description Entries
D007111 Immunity, Cellular Manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role. Cell-Mediated Immunity,Cellular Immune Response,Cell Mediated Immunity,Cell-Mediated Immunities,Cellular Immune Responses,Cellular Immunities,Cellular Immunity,Immune Response, Cellular,Immune Responses, Cellular,Immunities, Cell-Mediated,Immunities, Cellular,Immunity, Cell-Mediated,Response, Cellular Immune
D007694 Killer Cells, Natural Bone marrow-derived lymphocytes that possess cytotoxic properties, classically directed against transformed and virus-infected cells. Unlike T CELLS; and B CELLS; NK CELLS are not antigen specific. The cytotoxicity of natural killer cells is determined by the collective signaling of an array of inhibitory and stimulatory CELL SURFACE RECEPTORS. A subset of T-LYMPHOCYTES referred to as NATURAL KILLER T CELLS shares some of the properties of this cell type. NK Cells,Natural Killer Cells,Cell, NK,Cell, Natural Killer,Cells, NK,Cells, Natural Killer,Killer Cell, Natural,NK Cell,Natural Killer Cell
D006518 Hepatitis Viruses Any of the viruses that cause inflammation of the liver. They include both DNA and RNA viruses as well viruses from humans and animals. Hepatitis Virus, Marmoset,Hepatitis Virus,Hepatitis Viruses, Marmoset,Marmoset Hepatitis Virus,Marmoset Hepatitis Viruses,Virus, Hepatitis,Virus, Marmoset Hepatitis,Viruses, Hepatitis,Viruses, Marmoset Hepatitis
D006525 Hepatitis, Viral, Human INFLAMMATION of the LIVER in humans due to infection by VIRUSES. There are several significant types of human viral hepatitis with infection caused by enteric-transmission (HEPATITIS A; HEPATITIS E) or blood transfusion (HEPATITIS B; HEPATITIS C; and HEPATITIS D). Viral Hepatitis, Human,Human Viral Hepatitides,Human Viral Hepatitis,Viral Hepatitides, Human
D006526 Hepatitis C INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown. Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted,Parenterally-Transmitted Non-A, Non-B Hepatitis,PT-NANBH,Parenterally Transmitted Non A, Non B Hepatitis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies
D013602 T-Lymphocytes, Cytotoxic Immunized T-lymphocytes which can directly destroy appropriate target cells. These cytotoxic lymphocytes may be generated in vitro in mixed lymphocyte cultures (MLC), in vivo during a graft-versus-host (GVH) reaction, or after immunization with an allograft, tumor cell or virally transformed or chemically modified target cell. The lytic phenomenon is sometimes referred to as cell-mediated lympholysis (CML). These CD8-positive cells are distinct from NATURAL KILLER CELLS and NATURAL KILLER T-CELLS. There are two effector phenotypes: TC1 and TC2. Cell-Mediated Lympholytic Cells,Cytotoxic T Cells,Cytotoxic T Lymphocyte,Cytotoxic T-Lymphocytes,TC1 Cell,TC1 Cells,TC2 Cell,TC2 Cells,Cell Mediated Lympholytic Cells,Cell, Cell-Mediated Lympholytic,Cell, TC1,Cell, TC2,Cell-Mediated Lympholytic Cell,Cytotoxic T Cell,Cytotoxic T Lymphocytes,Cytotoxic T-Lymphocyte,Lymphocyte, Cytotoxic T,Lympholytic Cell, Cell-Mediated,Lympholytic Cells, Cell-Mediated,T Cell, Cytotoxic,T Lymphocyte, Cytotoxic,T Lymphocytes, Cytotoxic,T-Lymphocyte, Cytotoxic

Related Publications

K Yoshizawa, and K Kiyosawa, and S Furuta
February 1982, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
K Yoshizawa, and K Kiyosawa, and S Furuta
October 1981, Nihon rinsho. Japanese journal of clinical medicine,
K Yoshizawa, and K Kiyosawa, and S Furuta
March 1975, British medical journal,
K Yoshizawa, and K Kiyosawa, and S Furuta
May 1976, American journal of clinical pathology,
K Yoshizawa, and K Kiyosawa, and S Furuta
December 1979, Revista de medicina de la Universidad de Navarra,
K Yoshizawa, and K Kiyosawa, and S Furuta
January 1984, Terapevticheskii arkhiv,
K Yoshizawa, and K Kiyosawa, and S Furuta
December 1983, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
K Yoshizawa, and K Kiyosawa, and S Furuta
March 2003, Transplantation,
K Yoshizawa, and K Kiyosawa, and S Furuta
September 1980, Voprosy okhrany materinstva i detstva,
K Yoshizawa, and K Kiyosawa, and S Furuta
June 2018, Cellular & molecular immunology,
Copied contents to your clipboard!